Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase

US Patent 9783528 · Granted Oct 10, 2017

Estimated economic value: $6,673,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Deuterated OTX-0152020
Inhibitors of the enzyme UDP-glucose: N-acyl-sphingosine glucosyltransferase2019
Substituted triazolobenzodiazepines2019
Substituted xanthine derivatives2019
Substituted triazolobenzodiazepines2018
Deuterated pyrazino[2,1-a]isoquinoline compounds and methods of treatment using 2018
Substituted xanthine derivatives2018
Substituted triazolobenzodiazepines2017
Substituted thienotriazolodiazapines2017
Substituted xanthine derivatives2016
Substituted xanthine derivatives2016
Synthesis of deuterated morpholine derivatives2016